cardiology careers collections past issues search home
     

J Am Coll Cardiol, 2007; 49:716-726, doi:10.1016/j.jacc.2006.10.048 (Published online 8 December 2006).
© 2006 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow View NAPA Investigators
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mentzer, R. M.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Mentzer, R. M., Jr
Related Collections
Right arrowRelated Article

Effects of Perioperative Nesiritide in Patients With Left Ventricular Dysfunction Undergoing Cardiac Surgery

The NAPA Trial

Robert M. Mentzer, Jr, MD, FACC*,*, Mehmet C. Oz, MD, FACC{dagger}, Robert N. Sladen, MD, FCCM{ddagger}, Allen H. Graeve, MD, FACS§, Robert F. Hebeler, Jr, MD||, John M. Luber, Jr, MD, FACS, Nicholas G. Smedira, MD, FACC# on behalf of the NAPA Investigators

* Division of Cardiothoracic Surgery, Department of Surgery, Wayne State University School of Medicine, Detroit, Michigan
{dagger} Division of Cardiothoracic Surgery, College of Physicians & Surgeons, Columbia University, New York, New York
{ddagger} Department of Anesthesiology, College of Physicians & Surgeons, Columbia University, New York, New York
§ MultiCare Cardiothoracic Surgical Associates, Tacoma General Hospital, Tacoma, Washington
|| Department of Surgery, Baylor University Medical Center, Dallas, Texas
Franciscan Health System Research Center, Tacoma, Washington
# Department of Thoracic and Cardiovascular Surgery, The Cleveland Clinic, Cleveland, Ohio


Figure 1
View larger version (28K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 1 Analysis Populations

Consort diagram depicting the progress of the randomized patients over the course of the trial and their contribution to the various analysis groups.

 

Figure 2
View larger version (7K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 2 Time Course of SCr Response

Mean change from baseline in postoperative (post-op) serum creatinine (SCr) values over the course of the hospital stay in nesiritide (solid line) and placebo (dotted line) patients. Vertical lines signify 1 SEM. *p < 0.05 nesiritide versus placebo on the basis of longitudinal repeated measures analysis of variance model; {dagger}p < 0.05 change from baseline on the basis of paired t test. ICU = intensive care unit.

 

Figure 3
View larger version (12K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 3 Maximal Change in SCr and GFR by Baseline Renal Function

Adjusted mean maximum increase in serum creatinine (SCr) (A, B, and C) and decrease in glomerular filtration rate (GFR) (D, E, and F) from baseline through hospital discharge or by study day 14, whichever came first, using an analysis of covariance model. Lines above the bars represent 1 SEM.

 

Figure 4
View larger version (27K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 4 Time Course of Hemodynamic Parameters During the Initial 24 Postoperative Hours

Mean pulmonary artery pressure (A), pulmonary capillary wedge pressure (B), mean arterial pressure (C), central venous pressure (D), cardiac index (E), and systemic vascular resistance (F) at baseline and over the initial 24 postoperative hours in nesiritide (solid lines) and placebo (dotted lines) patients. Points represent mean values and vertical lines represent 1 SEM. The p values are for nesiritide versus placebo comparison using a longitudinal repeated measures analysis of variance model.

 

Figure 5
View larger version (18K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 5 Kaplan-Meier Survival Curve to Day 180 by Treatment Group in the Safety Population

 




 
  cardiology careers collections past issues search home